INTERSTELLAR - International Study Evaluating Lupus Outcomes after Anifrolumab Real World Use

Trial Identifier:	D3461R00072
Sponsor:	AstraZeneca
Start Date:	October 2024
Primary Completion Date:	March 2027
Study Completion Date:	March 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Kazakhstan	Aktobe, Kazakhstan
Kazakhstan	Almaty, Kazakhstan
Kazakhstan	Astana, Kazakhstan
Kazakhstan	Pavlodar, Kazakhstan
Kazakhstan	Semey, Kazakhstan
Kazakhstan	Shymkent, Kazakhstan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.